Clinical efficacy of ivabradine in patients with inappropriate sinus tachycardia: A prospective, randomized, placebo-controlled, double-blind, crossover evaluation

Journal of the American College of Cardiology

Volumn 60, Issue 15, 2012, Pages 1323-1329

  Cappato, Riccardo ^a   Castelvecchio, Serenella ^a   Ricci, Cristian ^b   Bianco, Elisabetta ^a   Vitali Serdoz, Laura ^a   Gnecchi Ruscone, Tomaso ^c   Pittalis, Mario ^a   De Ambroggi, Luigi ^a   Baruscotti, Mirko ^d   Gaeta, Maddalena ^a   Furlanello, Francesco ^a   Di Francesco, Dario ^a   Lupo, Pier Paolo ^a  

^a IRCCS POLICLINICO SAN DONATO   (Italy)

^b IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

^c A MANZONI HOSPITAL   (Italy)

^d UNIVERSITY OF PAVIA   (Italy)

Author keywords

antiarrhythmic drugs; inappropriate sinus tachycardia; ivabradine

Indexed keywords

IVABRADINE; PLACEBO;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CLINICAL FEATURE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIZZINESS; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; EXERCISE; FEMALE; FOLLOW UP; HEART RATE VARIABILITY; HOLTER MONITORING; HUMAN; INAPPROPRIATE SINUS TACHYCARDIA; LOW DRUG DOSE; MALE; NAUSEA; NONHUMAN; PHYSICAL CAPACITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINUS TACHYCARDIA; TREATMENT OUTCOME; VISUAL DISORDER; VOMITING; WEAKNESS;

ADMINISTRATION, ORAL; ADULT; BENZAZEPINES; CROSS-OVER STUDIES; CYCLIC NUCLEOTIDE-GATED CATION CHANNELS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART RATE; HUMANS; MALE; PROSPECTIVE STUDIES; SINOATRIAL NODE; TACHYCARDIA, SINUS; TREATMENT OUTCOME;

EID: 84867095585     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.06.031     Document Type: Article

References (21)

1. R.A. Bauernfeind, F. Amat-Y-Leon, R.C. Dhingra, R. Kehoe, C. Wyndham, K.M. Rosen Chronic nonparoxysmal sinus tachycardia in otherwise healthy persons Ann Intern Med 91 1979 702 710
2. A.D. Krahn, R. Yee, G.J. Klein, C. Morillo Inappropriate sinus tachycardia: evaluation and therapy J Cardiovasc Electrophysiol 6 1995 1124 1128
3. W.K. Shen Modification and ablation for inappropriate sinus tachycardia: current status Card Electrophysiol Rev 6 2002 349 355
4. C.A. Morillo, G.J. Klein, R.K. Thakur, H. Li, M. Zardini, R. Yee Mechanisms of inappropriate sinus tachycardia: role of sympathovagal imbalance Circulation 90 1994 873 877
5. W.K. Shen, P.A. Low, A. Jahangir Is sinus node modification appropriate for inappropriate sinus tachycardia with features of postural orthostatic tachycardia syndrome? Pacing Clin Electrophysiol 24 2001 217 230
6. W.K. Shen How to manage patients with inappropriate sinus tachycardia Heart Rhythm 2005 1015 1019
7. P.A. Chiale, H.A. Garro, J. Schmidberg Inappropriate sinus tachycardia may be related to an immunologic disorder involving adrenergic receptors Heart Rhythm 3 2006 1182 1186
8. D. DiFrancesco Pacemaker mechanisms in cardiac tissue Annu Rev Physiol 55 1993 455 472
9. S.S. Gottlieb, R.J. McCarter, R.A. Vogel Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction N Engl J Med 339 1998 489 497
10. A.J. Camm, C.P. Lau Electrophysiological effects of a single intravenous administration of ivabradine (S 16257) in adult patients with normal baseline electrophysiology Drugs R D 4 2003 83 89
11. M. Manz, M. Reuter, G. Lauck, H. Omran, W. Jung A single intravenous dose of ivabradine, a novel I(f) inhibitor, lowers heart rate but does not depress left ventricular function in patients with left ventricular dysfunction Cardiology 100 2003 149 155
12. V. Schulze, S. Steiner, M. Hennersdorf, B.E. Strauer Ivabradine as an alternative therapeutic trial in the treatment of inappropriate sinus tachycardia A case report Cardiology 110 2008 206 208
13. P.F. Winum, G. Cayla, M. Rubini, L. Beck, P. Messner-Pellenc A case of cardiomyopathy induced by inappropriate sinus tachycardia and cured by ivabradine Pacing Clin Electrophysiol 32 2009 942 944
14. J.S. Borer, J.C. Tardif Efficacy of ivabradine, a selective I(f) inhibitor, in patients with chronic stable angina pectoris and diabetes mellitus Am J Cardiol 105 2010 29 35
15. K. Swedberg, M. Komajda, M. Böhm SHIFT Investigators Ivabradine and outcomes in chronic heart failure (SHIFT): a randomized pacebo-controlled study Lancet 376 2010 875 885
16. M. Boehm, K. Swedberg, M. Kamajda SHIFT Investigators Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcome in a randomized placebo-controlled trial Lancet 376 2010 886 894
17. K. Fox, I. Ford, P.G. Steg, M. Tendera, R. Ferrari BEAUTIFUL Investigators Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomized, double-blind, placebo-controlled trial Lancet 372 2008 807 816
18. L. Calò, M. Rebecchi, A. Sette Efficacy of ivabradine administration in patients affected by inappropriate sinus tachycardia Heart Rhythm 7 2010 1318 1323
19. P. Bois, J. Bescond, B. Renaudon, J. Lenfant Mode of action of bradycardic agent, S 16257, on ionic currents of rabbit sinoatrial node cells Br J Pharmacol 118 1996 1051 1057
20. R.J. Lee, J.M. Kalman, A.P. Fitzpatrick Radiofrequency catheter modification of the sinus node for "inappropriate" sinus tachycardia Circulation 92 1995 2919 2928
21. E. Nof, C. Antzelevitch, M. Glickson The contribution of HCN4 to normal sinus node function in humans and animal models Pacing Clin Electrophysiol 2009 1 7